Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Shares Outstanding (Weighted Average) (2018 - 2025)

Exagen (XGN) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $21.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 18.43% year-over-year to $21.6 million, compared with a TTM value of $21.6 million through Dec 2025, up 18.43%, and an annual FY2025 reading of $21.6 million, up 18.43% over the prior year.
  • Shares Outstanding (Weighted Average) was $21.6 million for Q4 2025 at Exagen, down from $22.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $22.9 million in Q3 2025 and bottomed at $12.9 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $17.9 million, with a median of $17.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) skyrocketed 34.02% in 2021, then rose 0.57% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $16.0 million in 2021, then increased by 6.95% to $17.1 million in 2022, then grew by 3.5% to $17.7 million in 2023, then rose by 2.96% to $18.2 million in 2024, then grew by 18.43% to $21.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for XGN at $21.6 million in Q4 2025, $22.9 million in Q3 2025, and $21.1 million in Q2 2025.